data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Kiora Pharmaceuticals Inc

(NASDAQ:KPRX)

Perks Buy Compare Brokers

$0.52

-0.017[-3.17%]

Last update: 6:59PM (Delayed 15-Minutes)
Get Real Time Here

$0.52

0[0.00%]

After-Hours

Perks Buy Compare Brokers

Open-	Close-
Vol / Avg.0 / 106.293K	Mkt Cap3.998M
Day Range- - -	52 Wk Range0.462 - 8.515

0

Latest News for Kiora Pharmaceuticals Stock (NASDAQ:KPRX)

Kiora Pharmaceuticals Stock (NASDAQ: KPRX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, November 27, 2023

Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights - Nov 27, 2023, 9:43AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Nov 27, 2023, 8:06AM

Monday, November 13, 2023

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $3.5 Price Target
Benzinga Newsdesk - Nov 13, 2023, 10:31AM

Thursday, November 09, 2023

Kiora Pharmaceuticals: Q3 Earnings Insights
Benzinga Insights - Nov 9, 2023, 9:00AM
Kiora Pharmaceuticals Q3 EPS $(0.89) Up From $(6.03) YoY
Benzinga Newsdesk - Nov 9, 2023, 7:49AM

Monday, November 06, 2023

Analyst Expectations for Kiora Pharmaceuticals's Future
Benzinga Insights - Nov 6, 2023, 9:00AM
HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Raises Price Target to $3.5
Benzinga Newsdesk - Nov 6, 2023, 6:42AM
Kiora Pharmaceuticals Announced Topline Results Of Its Phase 1/2 Trial Demonstrating Proof-of-concept That KIO-301 Has The Potential To Meaningfully Improve Vision In Patients With Retinitis Pigmentosa With Ultra-low Vision Or Complete Blindness
Benzinga Newsdesk - Nov 6, 2023, 6:18AM

Tuesday, September 05, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Sep 5, 2023, 1:34PM

Thursday, August 24, 2023

Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin - Aug 24, 2023, 1:22PM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Aug 24, 2023, 9:06AM
Why Opera Shares Are Trading Lower By Around 12%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 24, 2023, 8:41AM
HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $2 Price Target
Benzinga Newsdesk - Aug 24, 2023, 6:24AM

Wednesday, August 23, 2023

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Aug 23, 2023, 5:32PM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights - Aug 23, 2023, 9:06AM
Kiora Pharmaceuticals Granted U.S. And European Patents For Local Ocular Delivery Of The KIO-100 Family Of Compounds
Charles Gross - Aug 23, 2023, 7:11AM

Monday, August 14, 2023

HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Lowers Price Target to $2
Benzinga Newsdesk - Aug 14, 2023, 6:38AM

Thursday, August 10, 2023

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Aug 10, 2023, 1:43PM

Wednesday, August 09, 2023

Maxim Group Maintains Buy on Kiora Pharmaceuticals, Lowers Price Target to $2
Benzinga Newsdesk - Aug 9, 2023, 1:01PM
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Aug 9, 2023, 12:27PM

Friday, July 21, 2023

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - Jul 21, 2023, 1:24PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Jul 21, 2023, 9:05AM
Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jul 21, 2023, 8:13AM
Late Thursday, Kiora Pharmaceuticals Received Deficiency Letter From NASDAQ; The Compliance Period For The Company Will Expire On January 15, 2024 - 8K
Benzinga Newsdesk - Jul 21, 2023, 4:20AM

Monday, June 26, 2023

Kiora Pharmaceuticals Has Been Granted European Patent Number EP3139914 Titled "Compounds For Treating Ophthalmic Diseases And Disorders"
Happy Mohamed - Jun 26, 2023, 12:49PM

Thursday, June 15, 2023

Kiora Pharmaceuticals Said Co And Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement For KIO-201; Amendment Eliminates $4.75M In Near-term Milestones Kiora Would Have Owed To Sentrx
Charles Gross - Jun 15, 2023, 5:12PM
Kiora Pharmaceuticals And Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement For KIO-201; Amendment Eliminates $4.75M In Near-term Milestones Kiora Would Have Owed To Sentrx
Benzinga Newsdesk - Jun 15, 2023, 7:16AM

Thursday, June 08, 2023

Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights - Jun 8, 2023, 12:25PM

Wednesday, June 07, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights - Jun 7, 2023, 12:38PM

Friday, June 02, 2023

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Jun 2, 2023, 1:31PM
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin - Jun 2, 2023, 1:00PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Jun 2, 2023, 9:07AM
Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jun 2, 2023, 7:58AM

Friday, May 19, 2023

Stocks That Hit 52-Week Lows On Friday
Benzinga Insights - May 19, 2023, 1:59PM

Tuesday, May 16, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - May 16, 2023, 1:01PM

Friday, May 12, 2023

HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Raises Price Target to $7
Benzinga Newsdesk - May 12, 2023, 7:07AM

Tuesday, May 09, 2023

Recap: Kiora Pharmaceuticals Q1 Earnings
Benzinga Insights - May 9, 2023, 10:03AM
Kiora Pharmaceuticals Q1 2023 Net Loss Of $(1.9)M Compared To $(3.6)M YoY; Kiora Ended Q1 With $3.4M In Cash & Cash Equivalents
Benzinga Newsdesk - May 9, 2023, 7:28AM

Monday, May 01, 2023

Kiora Pharmaceuticals Announced An Encore Presentation On KIO-301 Neuroimaging Results At The American Society Of Neuroradiology 2023 Meeting In Chicago
Benzinga Newsdesk - May 1, 2023, 7:22AM

Monday, April 17, 2023

Kiora Pharmaceuticals Initiates Phase 2 Trial Of KIO-101 For The Treatment Of Ocular Presentation Of Autoimmune Diseases
Benzinga Newsdesk - Apr 17, 2023, 7:11AM

Friday, March 24, 2023

Analyst Ratings for Kiora Pharmaceuticals
Benzinga Insights - Mar 24, 2023, 3:00PM
HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Lowers Price Target to $6
Benzinga Newsdesk - Mar 24, 2023, 12:34PM

Wednesday, March 08, 2023

Kiora Pharmaceuticals Insider Trades Send a Signal
Benzinga Insights - Mar 8, 2023, 10:02AM
Kiora Pharmaceuticals Director Awarded $31K Worth of Stock Options
Benzinga Insights - Mar 8, 2023, 10:01AM
Chief Development Officer at Kiora Pharmaceuticals Acquires Company Stock Options Worth 10,400 Shares
Benzinga Insights - Mar 8, 2023, 10:01AM
President and CEO at Kiora Pharmaceuticals Acquires Company Stock Options Worth 10,400 Shares
Benzinga Insights - Mar 8, 2023, 10:00AM
Board Member at Kiora Pharmaceuticals Acquires Company Stock Options Worth 8,000 Shares
Benzinga Insights - Mar 8, 2023, 10:00AM

Wednesday, March 01, 2023

EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In February — Including Tesla, Apple And A Surging AI Name
Chris Katje - Mar 1, 2023, 3:45PM

Tuesday, February 14, 2023

Collaboration With Kiora Pharmaceuticals And The Royal Adelaide Hospital, Leading Australian CRO, Accelagen Clinical Trial Underway To Improve Vision In Individuals With Advanced Retinitis Pigmentosa
Happy Mohamed - Feb 14, 2023, 4:22PM
FBI News sends SeqL Inc (SQL) Stock Surging
InvestorBrandMedia - Feb 14, 2023, 2:00PM

1
2
3
4
5
6
7
Next
17

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2023 Benzinga | All Rights Reserved